Keywords: Lonza, Vivante GMP Solutions, Viral vaccine and vector, M&A

Lonza acquires viral vaccine and vector manufacturer Vivante GMP Solutions

Article | 01 September 2010

Switzerland’s active pharmaceutical ingredients and specialty chemicals firm Lonza (LONN.VX) says it has acquired closely-held US firm Vivante ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lonza

Vivante GMP Solutions

Go to company listing